CERC stock forecast
Our latest prediction for Cerecor, Inc.'s stock price was made on the Feb. 3, 2020 when the stock price was at 3.98$.
In the short term (2weeks), CERC's stock price should outperform the market by 1.33%. During that period the price should oscillate between -10.63% and +14.51%.
In the medium term (3months), CERC's stock price should underperform the market by -11.26%. During that period the price should oscillate between -44.03% and +32.45%.Get email alerts
About Cerecor, Inc.
Cerecor, Inc. is a clinical stage biopharmaceutical company focuses in medical development. It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.
At the moment the company generates 20M USD in revenues.
On its last earning announcement, the company reported a loss of -0.46$ per share.
The book value per share is 0.55$
Three months stock forecastFeb. 3, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|